Related by context. All words. (Click for frequent words.) 74 Acute Heart Failure 73 Demonstrates Efficacy 73 Prospective Randomized 73 Oral Fingolimod 73 Shows Promise Against 72 First Patient Enrolled 72 Prolongs Survival 72 Tyrosine Kinase Inhibitor 72 Oral Calcitonin 72 Heart Failure Patients 72 Hormone Refractory Prostate Cancer 72 Anticancer Drug 72 Phase 2b Clinical Trial 72 Meets Primary Endpoint 72 Cardiotoxicity 72 Investigational Treatment 72 Randomized Double blind 72 Cardiac Resynchronization 71 Pooled Analysis 71 See CLINICAL PHARMACOLOGY 71 Patients Treated With 71 Clinical Trial Results 71 Nicotine Vaccine 71 Relapsing Multiple Sclerosis 71 Drug Shows Promise 71 Acute Decompensated Heart Failure 71 STRIDE PD 71 Diabetic Foot Ulcer 71 Completes Patient Enrollment 71 Initiates Enrollment 71 Hsp# Inhibitor 71 Fondaparinux 71 Left Ventricular Dysfunction 71 Metastatic Melanoma 71 Preclinical Data 70 Carotid Stenting 70 Advanced Melanoma 70 Phase 2a Clinical Trial 70 Slows Progression 70 Kidney Transplant Patients 70 Prospective Multicenter 70 Appears Safe 70 Disease Modifying 70 Anti Tumor 70 Patients Receiving 70 Combination REOLYSIN R 70 Schizophrenia Treatment 70 Recurrent Breast Cancer 70 HDL Selective Delipidation 70 Non Invasive Treatment 70 Romidepsin 70 Replacement Therapy 70 Initiates Phase III 70 Cardiac Stem Cell 70 Randomized Phase II 70 Investigational Drug 70 Clinical Trial Evaluating 70 Sleep Disturbances 70 Novel Therapeutic 70 Intervention Effectiveness 70 Aggressive Reduction 70 Improves Outcomes 70 Randomized Clinical Trial 70 Clinical Trial Data 70 Clinical Outcome 70 Patients Undergoing 70 Acute Ischemic Stroke 70 Metabolic Disorder 70 JAK Inhibitor 69 Renal Cancer 69 Demonstrates Positive 69 Long Term Efficacy 69 Hedgehog Pathway Inhibitor 69 Accelerated Partial Breast Irradiation 69 Successfully Completes Phase 69 Clinical Efficacy 69 Intracranial Aneurysms 69 Bone Metastases 69 Improve Survival 69 Peripheral Arterial 69 Immunomodulatory 69 Study Evaluating 69 Slow Progression 69 RNAi Therapeutic 69 Novel Oral 69 Improve Diagnosis 69 Drug Prevents 69 Treatment Shows Promise 69 Cervical Dysplasia 69 Dose Ranging Study 69 Gastric Cancer 69 Reduces Mortality 69 Combination Treatment 69 Pivotal Trial 69 Arterial Disease 69 Mimetics 69 Renal Cell Cancer 69 Systemic Sclerosis 69 Myocardial Ischemia 69 Advanced Heart Failure 69 Aneurysm Repair 69 Initiates Clinical Trial 69 Treating Chronic 69 Controlled Trial 69 Treatment Reduces 69 Malignant Glioma 69 Pivotal Study 69 Decompensated Heart Failure 69 Preclinical Study 69 Antitumor Activity 69 Phase III Clinical Trial 69 Phase Ib Clinical Trial 69 Rheumatoid Arthritis Patients 69 Aortic Valve 69 Risk Stratification 69 Shows Efficacy 69 II Clinical Trial 69 Phase 2b Trial 69 Pivotal Phase III 69 Valvular Heart Disease 69 Adjuvant Treatment 69 Phase IIb Clinical Trial 69 Therapeutic Targets 69 Small Molecule 68 Myoblast 68 Anti Tumor Activity 68 Novel Inhibitor 68 Teva Provides Update 68 Vaccine Protects Against 68 Antiangiogenic 68 Renal Artery 68 REMINDER ORLive Presents 68 Acute Renal Failure 68 Improves Survival 68 Adjuvant Chemotherapy 68 Randomized Double Blind 68 Acute Myocardial Infarction 68 Am J Geriatr 68 Glatiramer Acetate 68 Randomised 68 Phase 2a Trial 68 MAGE A3 ASCI 68 Less Invasive 68 Initiate Phase III 68 Plaque Psoriasis 68 Rotavirus Vaccine 68 Dose Escalation 68 Tumor Response 68 Metastatic Prostate Cancer 68 Carotid 68 Aflibercept 68 Bone Fracture 68 Left Ventricular 68 Enlarged Prostate 68 Study Shows Promise 68 Sapacitabine 68 Clinical Evaluation 68 Ranolazine 68 Proves Effective 68 Renal Cell Carcinoma 68 Postdoctoral Position 68 Skin Lesions 68 Randomized Study 68 Mycophenolate Mofetil 68 Pharmacodynamics 68 Receives Orphan Drug Designation 68 Preclinical Models 68 Initiates Clinical 68 Ischaemic 68 Infarct 68 Osteoarthritis Patients 68 Phase 2b Study 68 Atherosclerotic 68 Contrast Agents 68 Safinamide 68 fosbretabulin 68 Antigen Specific 68 Catheter Ablation 68 Paroxysmal Atrial Fibrillation 68 CHARM Added 68 acetonide FA 68 Cell Transplant 68 Acute Exacerbations 68 Levels Linked 68 Relapsing Remitting Multiple Sclerosis 68 Controlled Study 68 Diamyd Medical Diamyd 68 Pivotal Clinical Trial 68 Antiplatelet 68 R lenalidomide 68 JAK2 Inhibitor 68 Antiarrhythmic 68 Trial Evaluating 68 Initiates Phase II 68 Vulnerable Plaque 68 Heart Transplant Recipients 68 Meta Analysis 68 First Patient Dosed 68 Lung Cancer Drug 68 Presents Preclinical Data 68 Advanced Colorectal Cancer 68 Randomized controlled 68 Randomized Phase III 68 Venous Thromboembolism 68 Prevent Stroke 68 Novel Antibiotic 68 FDA Approvals 68 Adjunctive Therapy 68 Blocked Arteries 68 Dupuytren Disease 68 Protein Linked 68 Fixed Dose 68 Bucindolol 68 Extracorporeal Shock Wave 67 Low Dose 67 Radiofrequency Ablation 67 Cognitive Impairment 67 Cholesterol Lowering Drug 67 Eculizumab 67 Myelodysplastic Syndromes 67 Demonstrates Sustained 67 ST Elevation Myocardial 67 #-# Full Text 67 Statistically Significant 67 Therapy Improves 67 Overactive Bladder 67 Knee Osteoarthritis 67 Selective Cardiac Myosin Activator 67 Single Incision 67 HCV Protease Inhibitor 67 orally inhaled migraine 67 number NCT# ClinicalTrials.gov 67 FDA Okays 67 multicentre randomized controlled 67 Atypical Antipsychotic 67 Thiazolidinediones 67 Fungal Infections 67 Randomized Controlled Trials 67 Microplasmin 67 Randomized Evaluation 67 Laryngeal Cancer 67 Aortic Dissection 67 riociguat 67 Nebulized 67 Ischemic 67 Cardiovascular Outcomes 67 Tyrosine Kinase Inhibitors 67 #:#-#,# CrossRef Medline [002] 67 Pulmonary Arterial Hypertension 67 Golimumab 67 Circulatory Support 67 Diabetic Neuropathy 67 Intravenous Formulation 67 Localized Prostate Cancer 67 Patient Outcomes 67 Valve Replacement 67 Hepatocellular Carcinoma 67 Adjunctive 67 Intravenous Immunoglobulin 67 Aurora Kinase 67 Hernia Repair 67 Pharmacokinetic Study 67 Renal Function 67 Differential Diagnosis 67 Coronary Artery Bypass Graft 67 Lowers Risk 67 Autoimmune Disease 67 Demonstrate Significant 67 Treated Patients 67 Intra Arterial 67 CYT# potent vascular disrupting 67 Completes Enrollment 67 Minimally Invasive Treatment 67 immunomodulatory agents 67 Metabolic Disease 67 Liver Metastases 67 Lung Cancer Trial 67 Successfully Treats 67 Cholesterol Levels SPARCL 67 Prostate Cancer Vaccine 67 Podium Presentation 67 Prognostic Value 67 Image Guided 67 Progenitor Cells 67 ST Segment Elevation 67 Anti Clotting Drug 67 CCX# B 67 Spinal Disc 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 Dupuytren Contracture 67 Stereotactic Body Radiation Therapy 67 Pharmacologic 67 Bioresorbable 67 Hematological 67 CIMZIA TM certolizumab pegol 67 Ischemic Stroke 67 Inflammatory Diseases 67 Newly Diagnosed Breast Cancer 67 Files IND 67 delivers fluocinolone acetonide FA 67 Preclinical Efficacy 67 Multiple Myeloma Patients 67 RhuDex 67 Antithrombotic 67 Immunomedics Announces 67 Lumbar Spine 67 Transplant Rejection 67 Delcath Phase III 67 Investigational Compound 67 Chronic Heart Failure 67 Hospital Acquired Pneumonia 67 Cervical Spine 67 Diabetic Nephropathy 67 IND Application 67 Coronary Angiography 67 Unfractionated Heparin 67 Myocardial Perfusion Imaging 67 Randomized Phase 67 Stem Cell Treatment 67 ANN INTERN MED 67 Naive Patients 67 Unstable Angina 67 Sustained Efficacy 67 Prophylactic Treatment 67 Antitumor 67 Anticancer Activity 67 Unresectable 67 Breast Brachytherapy 67 Chronic Sinusitis 67 Motexafin Gadolinium 67 Therapeutic Efficacy 66 Prolongs Life 66 Transdermal Patch 66 Coronary Revascularization 66 Bipolar Depression 66 Sipuleucel T 66 Efficacy Trial 66 Novel Mechanism 66 Late Breaker 66 Orthostatic Hypotension 66 Total Knee Arthroplasty 66 Universal Flu Vaccine 66 Phase III Trial 66 Diastolic Heart Failure 66 Inhaled Nitric Oxide 66 Prognostic Factors 66 Arthritis Drugs 66 Surgical Treatment 66 Renal Impairment 66 Synthetic Peptide 66 NAVISTAR R 66 INSPIRE Trial Phase III 66 KRN# 66 Initiate Phase II 66 Inflammatory Arthritis 66 Venous Thrombosis 66 Aliskiren 66 Neoadjuvant Chemotherapy 66 Antiplatelet Therapy 66 Targeted Therapy 66 Subgroup Analysis 66 Atypical Hemolytic Uremic Syndrome 66 Skeletal Muscle 66 Abstract Accepted 66 Advanced Renal Cell 66 Crit Rev 66 Intracerebral Hemorrhage 66 Gout Drug 66 Septic Shock 66 Oral Presentations 66 Breast Density 66 Carotid Revascularization Endarterectomy vs. 66 Mg Usa 66 Causes Symptoms 66 Resistant Hypertension 66 Multicenter Randomized 66 Drug Candidate 66 Initiate Phase 66 acute peripheral arterial 66 Contrast Agent 66 Hypertensive Patients 66 Onyx Pharmaceuticals Announces 66 Novel Approaches 66 Novel Compound 66 Carotid Endarterectomy 66 Anticoagulant 66 Transcatheter 66 Kinase Inhibitor 66 Test Detects 66 Autoimmune Diseases 66 Randomized Controlled 66 Thrombotic 66 Diabetic Kidney Disease 66 Epilepsy Drug 66 intravesical infusion therapy 66 Immunotherapeutic 66 Antibody Drug Conjugate 66 Present Preclinical Data 66 Confirmatory Phase 66 Double Blind Placebo 66 Menstrual Pain 66 Improve Outcomes 66 Severe Asthma 66 Cancer Stem Cells 66 recurrent glioblastoma multiforme 66 Female Urology 66 Percutaneous Coronary Intervention 66 Biomarker Study 66 Hematological Malignancies 66 Shown Effective 66 Synta Announces 66 Relapsed Multiple Myeloma 66 Predict Response 66 Edge STudy 66 Severe Sepsis 66 Phase Ib IIa 66 Patient Enrollment 66 Bipolar Mania 66 Acute Coronary Syndromes 66 Microalbuminuria 66 Secondary Hyperparathyroidism 66 Phase IIb Trial 66 Improved Survival 66 Protease Inhibitor 66 relapsed MM 66 undergoing Percutaneous Coronary 66 Poster Discussion 66 HER2 Positive 66 Effectively Treats 66 Benign Prostatic Hyperplasia 66 Novel Treatments 66 Uterine Cancer 66 Corneal Transplant 66 Chemotherapeutic Agents 66 Central Retinal Vein 66 Reduced Risk 66 Glucosamine Chondroitin Arthritis 66 Multicenter 66 Cognitive Deficits 66 PEGylated interferon beta 1a 66 Kidney Transplant Recipients 66 Trandolapril 66 Muscle Wasting 66 Malignant Melanoma 66 Hematological Cancers 66 ACE Inhibitors 66 Minimally Invasive Procedure 66 Adult Stem Cell Therapy 66 Therapy Reduces 66 Desvenlafaxine Succinate 66 Sirolimus eluting 66 Critical Limb Ischemia CLI 66 Ataluren 66 Phase #b/#a clinical 66 Pivotal Phase 66 Lung Injury 66 Teriparatide 66 Clostridium difficile Infection 66 registrational Phase 66 Lupus Nephritis 66 Melphalan 66 B Cell Malignancies 66 Second Pivotal Phase 66 Reduce Cardiovascular 66 Breast Cancer Recurrence 66 Drug Fails 66 Colorectal Cancer Patients 66 Dose Ranging 66 Coronary Arteries 66 Vascugel 66 Granted Orphan Drug 66 Genetic Markers 66 Muscle Function 66 Liver Failure 66 unfractionated heparin UFH 66 Bioequivalence 66 Antipsychotic Medications 66 Initiate Clinical Trial 66 Critical Limb Ischemia 66 Daclizumab 66 Intravascular 66 FDA Approves Drug 66 Selective Cardiac Myosin 66 Phase III multicenter 66 Mouse Model 66 Multicenter Phase 66 LibiGel ® 66 Diagnostic Criteria 66 Chemoradiation 66 Stereotactic Radiosurgery 66 Epidermal Growth Factor Receptor 66 Prostate Cancer Treatment 66 Multicenter Trial 66 Embolization 66 Interferon Beta 66 Heterozygous Familial Hypercholesterolemia 66 Helps Smokers Quit 66 RECORD1 66 Vascular Ultrasound 66 Submits NDA 66 Attenuates 66 Tuberculosis Vaccine 66 Immunosuppression 66 Degarelix 66 Prostate Cancer Patients 66 Antiviral Therapy 66 Vaccine Candidate 66 #:#-#,# CrossRef Medline [001] 66 Nesiritide 65 Inflammatory Markers 65 Postmenopausal Osteoporosis 65 Molecular Basis 65 Psoriasis Drug 65 ADMIRE HF 65 Silodosin 65 Study Shows Benefits 65 Acute Stroke 65 Chronic Wounds 65 HORIZONS AMI 65 Anti Inflammatory Drug 65 Thromboembolic 65 Demonstrates Potent 65 novel VDA molecule 65 Oral Insulin 65 Intravitreal 65 Beta Blocker 65 Squamous Cell Carcinoma 65 Aptamer 65 Cannabinor 65 Treating Depression 65 Soft Tissue Sarcoma 65 Metastatic Renal Cell Carcinoma 65 Vaccine Adjuvants 65 beta 1a 65 IMPACT DCM 65 Hepatitis C Infection 65 Phase IIa Clinical Trial 65 Platelet Inhibition 65 Romiplostim 65 Dose Response 65 Genes Linked 65 Develop Novel 65 Peripheral Vascular Disease 65 Oncologic 65 Cancer Vaccines 65 Trigeminal Neuralgia 65 Leukemia Cells 65 Genes Identified 65 Tissue Engineered 65 Uterine Fibroid Embolization 65 CT Angiography 65 recurrent metastatic ovarian cancer 65 NASH Huntington 65 Thromboembolism 65 External Beam 65 Angiographic 65 Bivalirudin 65 Pediatric Patients 65 Imaging Technique 65 Pafuramidine 65 Complicated Skin 65 Endothelial Function 65 Placebo Controlled Study 65 Transplant Patients 65 SNT-MC#/idebenone 65 Outpatient Setting 65 Boosts Survival 65 Drug Eluting 65 Shows Promising 65 Tissue Repair 65 Long Term Survival 65 Eluting Stent 65 Regenerative Cell 65 Percutaneous Tibial Nerve Stimulation 65 AFRS TM 65 Capsules CII 65 Allogeneic 65 Treatment Naive Patients 65 Therapeutic Antibody 65 Tiotropium 65 Ventricular Arrhythmias 65 Deforolimus 65 Vaccine Immunology 65 Endarterectomy 65 Lung Cancer Survival 65 Guidelines Issued 65 Orphan Diseases 65 Statin Therapy 65 Pemetrexed 65 Placebo Controlled Trial 65 Pegylated Liposomal Doxorubicin 65 Inhaled Corticosteroids 65 Pertuzumab 65 Oral Mucositis 65 INS# [002] 65 evaluating picoplatin 65 Pyridorin 65 Acute Treatment 65 #:#-#,# [002] 65 Rigel R# 65 Survival Benefit 65 Non Alcoholic Fatty 65 Vertebral Compression Fractures 65 coronary stent merged 65 Tumor Microenvironment 65 Clin J 65 Chronic Pelvic Pain 65 J Am Coll 65 Limb Ischemia 65 Therapeutic Vaccine 65 Non inferiority 65 Ovarian Cancers 65 Proven Effective 65 Successfully Treated 65 Castration Resistant Prostate Cancer 65 CLARITY TIMI 65 Blood Cancers 65 Recurrent Glioblastoma 65 Demonstrates Significant 65 Male Contraceptive 65 Focused Ultrasound 65 Antiviral Activity 65 EXPLORE Xa 65 Reperfusion Injury 65 Ancrod 65 Lupus Drug 65 undergoing elective percutaneous 65 Inflammatory Disease 65 Double Blind Randomized 65 Treating Heart Failure 65 Interventional Procedures 65 Patients Suffering 65 Randomized Clinical Trials 65 ASCO GI 65 vapreotide acetate 65 Chronic HCV 65 Mesothelioma Treatment 65 Placebo Controlled 65 Critically Ill Patients 65 Gene Linked 65 MKC# MT 65 Magnetic Nanoparticles 65 Initiates Phase 2b 65 Anthracycline 65 Kinase Inhibitors 65 Amniotic Fluid 65 Aeolus Pharmaceuticals Announces 65 Helps Diagnose 65 Blood Pressure Drug 65 Enhanced External Counterpulsation 65 5 Fluorouracil 65 Diagnostic Tests 65 CIPN 65 Hyperlipidemia 65 Cocaine Addiction 65 Artery Disease 65 Estrogen Therapy 65 Decitabine 65 Cinacalcet 65 AVI BioPharma Announces 65 Surgical Treatments 65 Beneficial Effects 65 Presents Positive 65 J Clin 65 Enrolling Patients 65 atypical Hemolytic Uremic Syndrome 65 Increased Mortality 65 TransVax ™ 65 Tolvaptan 65 Expanded Indication 65 Phase III Pivotal 65 Analytical Tool 65 Liprotamase 65 Spinal Fractures 65 Clinical Validation 65 Peginterferon 65 Randomized Trials 65 RCW Breast Cancer 65 Radiation Induced 65 Occlusive Disease 65 C1 Inhibitor 65 Glucocorticoid 65 Trodusquemine MSI 65 Myocardial Infarction Study 65 dual endothelin receptor antagonist 65 RE MODEL 65 Maven Semantic 65 Ovarian Cancer Patients 65 Spinal Fusion 65 Telik Announces 65 Hepatitis C Antiviral 65 Confirms Efficacy 65 either acutely decompensated 65 recurrent glioma 65 Rheumatoid Arthritis Drug 65 HDAC Inhibitor 65 Proc Am Soc 65 Serious Infections 65 Drug Combo 65 Allograft 65 chronic myocardial ischemia 65 Gentium Announces 65 Chronic Lymphocytic Leukemia 65 Hypertrophy 65 Reduces Pain 65 Breast Carcinoma 65 Anticancer Drugs 65 Hepatotoxicity 65 Arthritis Drug 65 Invasive Breast Cancer 65 Prostate AdenoCarcinoma Treatment 65 Opioid Dependence 65 Interferon Gamma 65 Stent Thrombosis 65 Investigational Agent 65 EVEREST II 64 Study Demonstrates 64 Sandostatin R 64 Treat Heart Failure 64 Placebo controlled 64 ENDEAVOR IV 64 Vaccine Shows Promise 64 EVIZON TM 64 Metabolic Efficiency 64 Transdermal Delivery 64 Optical Coherence Tomography 64 Vicriviroc 64 Viral Infections 64 Bladder Cancer 64 Respiratory Virus 64 Microwave Ablation System 64 Coronary Artery Calcium 64 Talabostat 64 Hematopoietic Stem Cell Transplantation 64 Adenoma 64 Antifungal 64 CLINICAL PHARMACOLOGY 64 Polymerase Inhibitor 64 Elagolix 64 Oral Cavity 64 Early Diagnosis 64 Vaccine Adjuvant 64 Lung Cancer Patients 64 Estrogen Receptor 64 HER2 Positive Breast Cancer 64 Randomized Placebo controlled 64 Thyroid Hormone 64 Eluting 64 Osteoporosis Drugs 64 interferon alpha IFN 64 Remission Maintenance 64 Thrombolytic 64 NPS Pharmaceuticals Announces 64 Long Term Outcomes 64 Fallopian Tube 64 Potent Antiviral Activity 64 Neovascular Age Related Macular 64 Post Operative 64 Therapy Evaluation 64 Atopic Dermatitis 64 NDA Submission 64 Demonstrates Statistically Significant 64 Glaucoma Treatment 64 Phase III Pivotal Trial 64 Contrast Enhanced 64 Diabetic Macular Edema DME 64 Mouse Models 64 Eur J 64 Treatment Resistant 64 Xelox 64 Asthma Treatment 64 TRO# 64 Systemic Lupus Erythematosus SLE 64 MEK Inhibitor 64 Node Positive 64 EchoCRT 64 Abciximab 64 MGd 64 CNS Disorders 64 Nonalcoholic Steatohepatitis 64 Carcinoid Syndrome 64 Novel Therapies 64 Smooth Muscle 64 Initiated Phase 64 Bazedoxifene 64 Embolic Protection Device 64 Neurogenic 64 Ad5FGF 4 64 Bone Marrow Cells 64 Kidney Function 64 Clinical Antipsychotic Trials 64 Pulmonary Vein Isolation 64 Androxal TM 64 Enzyme Replacement Therapy 64 Rilonacept 64 Angiox ® 64 Overactive Bladder OAB 64 Postmenopausal Women 64 Hormone Receptor Positive 64 CARE HF 64 Methylnaltrexone 64 Denufosol 64 ThermoDox ® clinical 64 Sustained Reduction 64 Cutaneous T 64 Glufosfamide 64 Dual Antiplatelet Therapy 64 Novel Therapeutics 64 Patients Treated 64 allogeneic hematopoietic stem cell 64 FASEB J. 64 Rheumatoid 64 Drug Eluting Stents 64 Carotid Artery Stenting 64 Rheos System 64 AA Amyloidosis 64 Excessive Sweating 64 Disease Modification 64 Collaborators Present 64 BRIM2 64 Female Sexual Arousal 64 Chemoprevention 64 GW# [003] 64 Chelation Therapy 64 Tigecycline 64 Neuroprotective Effects 64 Vildagliptin 64 Migraine Treatment 64 Bone Mineral Density 64 Circulating Tumor Cells 64 Robot Assisted 64 Osteoporosis Treatment 64 Renal Anemia 64 CCR5 mAb 64 Fibromyalgia Pain 64 ORLive Presents 64 Intervention Effectiveness CATIE 64 Induction Therapy 64 Pivotal Phase II 64 First Patient Treated 64 Male Infertility 64 Cancer AACR NCI 64 Brain Atrophy 64 Chronic Liver Disease 64 Phase III Clinical Trials 64 FOLFOX6 chemotherapy regimen 64 Etanercept 64 Heart Transplantation 64 descending thoracic 64 Helps Predict 64 Protease Inhibitors 64 Cardiac Resynchronization Therapy 64 treat benign prostatic 64 GORE TAG Device 64 kidney urologic 64 Balloon Angioplasty 64 Preterm Labor 64 Medtronic CoreValve ® 64 Personalized Immunotherapy 64 Artificial Liver 64 Cyclooxygenase 2 64 Recombinant Human 64 galiximab 64 Tanespimycin 64 RNAi Therapeutics 64 Therapeutic Potential 64 Dose Finding 64 Left Atrial 64 Stent Coating 64 Arch Neurol 64 Seasonal Influenza Vaccine 64 Solid Malignancies 64 Diabetic Macular Edema 64 Research www. elsevier.com 64 SUTENT ® 64 Catheter Associated 64 Liver Injury 64 Lung Tumors 64 Tezampanel 64 Adjuvant Therapy 64 Bare Metal Stents 64 Anti Inflammatory Drugs 64 PREGNANT PROCHIEVE ® 64 Hormone Replacement 64 Vascular Grafts 64 multicenter multinational 64 Aortic Stenosis 64 Pivotal Trials 64 Contraindications 64 Colorectal Cancers 64 Hypertriglyceridemia 64 Intravesical 64 ASSERT 64 Crofelemer budesonide foam 64 ENESTnd 64 orally administered inhibitor 64 lexidronam injection 64 Cardiac Arrhythmias 64 Parathyroid Hormone 64 Treatment Regimen 64 Fibroblast 64 Raloxifene STAR 64 Aggressive Drug Evaluation 64 Spine Patient Outcomes 64 Refractory Hodgkin Lymphoma 64 Single Dose 64 Juvenile Idiopathic Arthritis 64 Brain Metastases 64 BiTE Antibody 64 Cardiovascular Disease Risk 64 Bronchiectasis 64 Newly Diagnosed Multiple Myeloma 64 Breast Tumor 64 Clot Busting 64 Who Underwent 64 Cardiovascular Risk Reduction 64 Pelvic Organ Prolapse 64 GRNCM1 64 IL# PE#QQR 64 Poster Presentations 64 Tasigna prolongs 64 Chronic Renal Failure 64 Simulect 64 Resubmission 64 Neuroendocrine Tumors 64 Virtual Colonoscopy 64 Aortic Valve Replacement 64 Hepatitis C Genotype 64 Randomized Placebo Controlled 64 toenail onychomycosis 64 Virus Linked 64 cMET 64 Apixaban 64 Often Misdiagnosed 64 Visceral Fat 64 Anti Angiogenic 64 Thrombus 64 Cardiovascular Imaging 64 Angiogenic 64 Combo Therapy 64 Stent Restenosis 64 oral prodrug 64 Peripheral Blood 64 Tumor Growth 64 Novel Small Molecule 64 Innate Immune 64 STENT 64 Endometrial Cancer 64 TORISEL TM 64 Cerebril TM 64 Enzastaurin 64 Sustained Release 64 evaluating satraplatin plus 64 TransVax 64 Fracture Risk 64 Ridaforolimus 64 Healthbeat Report 64 Varicose Vein 64 Robotic Assisted 64 CHAMPION PCI 64 Antipsychotic Drug 64 Relieves Pain 64 Cytochrome P# 64 Multicenter Randomized Double 64 Improve Patient Outcomes 64 Periodontal Disease 64 Multiple Ascending Dose 64 Demonstrated Significant 64 Stable Angina 64 Bayer HealthCare Onyx Pharmaceuticals 64 CINQUIL 64 Angiotensin Converting Enzyme 64 FIX HF 5 64 Treat Parkinson Disease 64 Regenerative Cells 64 pralatrexate injection folate analogue 64 Preterm Delivery 64 Bare Metal Stent 64 Oral Anticoagulant 64 somatostatin analog 64 ASCO Breast Cancer 64 Acute Attacks 64 Surgical Procedures 64 Infected Patients 63 Autoimmune Disorders 63 NICE Recommends 63 ASTEROID 63 PDX pralatrexate 63 Nanoemulsion 63 targeted radiotherapeutic 63 Diabetic Neuropathic Pain 63 RhuDex R 63 Solid Tumor 63 metastatic malignant 63 Protein Expression 63 Pegloticase 63 mecarbil 63 Left Ventricular Hypertrophy 63 Statin Drugs